A new study in mice finds that the ketogenic, or keto, diet helps to eliminate the side effects of a new generation of cancer drugs.
In recent years, scientists have been testing a new class of cancer drugs.
They target a specific molecular pathway that has been shown to be faulty in many types of cancer.
Specifically, these drugs target a cell signaling pathway called phosphatidylinositol-3 kinase (PI3K), which is activated by insulin.
